A proteomic approach to elucidate the multiple targets of selenium-induced cell-growth inhibition in human lung cancer

Xiaorong Zhong, Lu Li, Min Wang, Wei Luo, Qingwei Tan, Feng Xu, Wen Zhu, Qi Wang, Ting Wang, Mei Hou, Nagalakshmi Nadimity, Xingyang Xue, Jun Chen, Wei Ma, Allen C Gao, Qinghua Zhou

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Background: Methylseleninic acid (MSA) has been implicated as a promising anticancer agent for lung cancer. However, the underlying molecular mechanism(s) responsible for MSA's action is not well understood. Our study aimed to examine the cellular effects of MSA on L9981 human high-metastatic large cell lung cancer cells and gain insights into its possible molecular mechanism(s) through a proteomic approach. Methods: L9981 cells were exposed to MSA at different concentrations and time points. The effects of MSA on cell proliferation and apoptosis were detected by cell viability analyzer Vi-CELL and flow cytometric analysis, respectively. We analyzed the alterations in the proteome profile of L9981 cells induced by MSA using the 2-D difference in gel electrophoresis (2-D DIGE) and identified the differentially expressed proteins using a liquid chromatography system followed by tandem mass spectrometry (LC-MS/MS). Results: We found that MSA inhibited cell proliferation in a dose-dependent manner and significantly induced early apoptosis in L9981 cells. 2-D DIGE showed that MSA induced significant changes (>1.29 fold) in the expression levels of 42 protein spots compared to the untreated control (P < 0.05). As identified by LC-MS/MS, proteins that underwent changes in response to MSA were related to various biological functions, including: (i) endoplasmic reticulum stress (upregulation of molecular chaperones like heat shock protein A5, protein disulfide-isomerase precursor, and calreticulin precursor); (ii) oxidative stress response/thioredoxin system (decreased thioredoxin-like protein 1 and increased thioredoxin reductase 1); (iii) translation regulation (downregulation of translation factors like elongation factor 1-beta and eukaryotic translation initiation factor 6); (iv) mitochondrial bioenergetic function (upregulation of adenosine triphosphate synthase subunit beta and mitochondria); and (v) cell signal transduction regulation (decreased peptidyl-prolyl cis-trans isomerase A and 14-3-3 protein gamma). The protein and gene expression levels of those proteins of interest were further confirmed by Western blot and/or real-time reverse transcription polymerase chain reaction. Conclusion: Our results suggest that MSA may inhibit cell proliferation and induce apoptosis in lung cancer by modulating multiple targets involved in various crucial cellular processes.

Original languageEnglish (US)
Pages (from-to)164-178
Number of pages15
JournalThoracic Cancer
Volume2
Issue number4
DOIs
StatePublished - Nov 2011

Keywords

  • 2-D DIGE
  • Apoptosis
  • Growth inhibition
  • LC-MS/MS
  • Lung cancer
  • Methylseleninic acid

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'A proteomic approach to elucidate the multiple targets of selenium-induced cell-growth inhibition in human lung cancer'. Together they form a unique fingerprint.

  • Cite this

    Zhong, X., Li, L., Wang, M., Luo, W., Tan, Q., Xu, F., Zhu, W., Wang, Q., Wang, T., Hou, M., Nadimity, N., Xue, X., Chen, J., Ma, W., Gao, A. C., & Zhou, Q. (2011). A proteomic approach to elucidate the multiple targets of selenium-induced cell-growth inhibition in human lung cancer. Thoracic Cancer, 2(4), 164-178. https://doi.org/10.1111/j.1759-7714.2011.00066.x